The effect of apheresis on adhesion molecules

Therapeutic Apheresis

Volumn 7, Issue 4, 2003, Pages 425-430

  Motohashi, Kazuko ^a   Yamane, Shingo ^a  

^a Tokatsu Clinic Hospital   (Japan)

Author keywords

Adhesion molecules; Hyperlipidemia LDL apheresis

Indexed keywords

CELL ADHESION MOLECULE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; INTERCELLULAR ADHESION MOLECULE 1; LOW DENSITY LIPOPROTEIN; PADGEM PROTEIN; VASCULAR CELL ADHESION MOLECULE 1;

AORTA ATHEROSCLEROSIS; APHERESIS; CARDIOVASCULAR RISK; CELL INTERACTION; ENDOTHELIUM CELL; HUMAN; HYPERCHOLESTEROLEMIA; HYPERLIPIDEMIA; ISCHEMIC HEART DISEASE; LEUKOCYTE; PLASMA; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; REVIEW; RISK ASSESSMENT; TREATMENT OUTCOME;

ARTERIOSCLEROSIS; CELL ADHESION MOLECULES; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; HYPERLIPIDEMIAS; INTERCELLULAR ADHESION MOLECULE-1; LIPOPROTEINS, LDL; MALE; PLASMAPHERESIS; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; VASCULAR CELL ADHESION MOLECULE-1;

EID: 0042817875     PISSN: 10916660     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1526-0968.2003.00079.x     Document Type: Review

References (48)

1. Kitabatake A, Sato H, Hori M et al. Coronary atherosclerosis reduced in patients with familial hypercholesterolemia after intensive cholesterol lowering with low-density lipoprotein-apheresis: 1-year follow-up study. The Osaka LDL apheresis Multicenter Trial Group. Clin Ther 1994;16:416-28.
2. Tamai O, Matsuoka H, Itabe H, Wada Y, Kohno K, Imaizumi T. Single LDL apheresis improves endothelium-dependent vasodilation in hypercholesterolemic humans. Circulation 1997;95:76-82.
3. Uno H, Ueki Y, Murashima J et al. Removal of LDL from plasma by adsorption reduces adhesion molecules on mononuclear cells in patients with arteriosclerosis obliterans. Atherosclerosis 1995;116:93-102.
4. Frenette PS, Wagner DD. Adhesion molecules-Part II: Blood vessels and blood cells. N Engl J Med 1996;335:43-5.
5. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1993;362:801-9.
6. Butcher EC. Leukocyte-endothelial cell recognition: three (or more) steps to specificity and deliversity. Cell 1991;67:1033-6.
7. Morisaki N, Saito I, Tamura K et al. New indices of ischemic heart disease and aging: studies on the serum levels of soluble intercellular adhesion molecule-1 (ICAM-1) and soluble vascular cell adhesion molecule-1 (VCAM-1) in patients with hypercholesterolemia and ischemic heart disease. Atherosclerosis 1997;131:43-8.
8. Peter K, Nawroth P, Conradt C et al. Circulating vascular cell adhesion molecule-1 correlates with the extent of human atherosclerois in contrast to circulating intercellular adhesion molecule-1, E-selectin, P-selectin, and thrombomodulin. Arterioscler Thromb Vasc Biol 1997;17:505-12.
9. Nakai K, Itoh C, Kawazoe K et al. Concentration of soluble vascular cell adhesion molecule-1 (VCAM-1) correlated with expression of VCAM-1 mRNA in the human atherosclerotic aorta. Coron Artery Dis 1995;6:497-502.
10. Carlos TM, Harlan JM. Leukocyte-endothelial adhesion molecules. Blood 1994;84:2068-101.
11. Smith CW, Marlin SD, Rothlein R, Toman C, Anderson DC. Cooperative interactions of LFA-1 and Mac-1 with intercellular adhesion molecule-1 in facilitating adherence and transendothelial migration of human neutrophils in vitro. J Clin Invest 1989;83:2008-17.
12. Elices MJ, Osborn L, Takada Y et al. VCAM-1 on activated endothelium interacts with the leukocyte integrin VLA-4 at a site distinct from the VLA-4/fibronectin binding site. Cell 1990;60:577-84.
13. O'Brien KD, McDonald TO, Chait A, Allen MD, Alpers CE. Neovascular expression of E-selectin, intercellular adhesion molecule-1, and vascular cell adhesion molecule-1 in human atherosclerosis and their relation to intimal leukocyte content. Circulation 1996;93:672-82.
14. Philips ML, Nudelman E, Gaeta FC et al. ELAM-1 mediates cell adhesion by recognition of a carbohydrate ligand, sialyl-Lex. Science 1990;250:1130-2.
15. Bonfanti R, Furie BC, Furic B, Wagner DD. PADGEM (GMP 140) is a component of Weibel-Palade bodies of human endothelial cells. Blood 1989;73:1109-12.
16. Furie B, Furie BC. The molecular basis of platelet and endothelial cell interaction with neutrophils and monocytes: role of P-selectin and the P-selectin ligand, PSGL-1. Thromb Haemost 1995;74:224-7.
17. Smith CW, Kishimoto TK, Abbassi O et al. Chemotactic factors regulate lectin adhesion molecule 1 (LECAM-1) -dependent neutrophil adhesion to cytokine-stimulated endothelial cells in vitro. J Clin Invest 1991;87:609-18.
18. Baumheter S, Singer MS, Henzel W et al. Binding of 1-selectin to the vascular sialomucin CD34. Science 1993;262:436-8.
19. Takami S, Yamashita S, Kihara S et al. Lipoprotein (a) enhances the expression of intercellular adhesion molecules-1 in cultured human umbilical vein endothelial cells. Circulation 1998;97:721-8.
20. Zhao SP, Xu DY. Oxidized lipoprotein (a) enhanced the expression of P-selectin in cultured human umbilical vein endothelial cells. Thromb Res 2000;100:501-10.
21. Kume N, Cybulsky MI, Gimbrone MA Jr. Lysophosphatidylcholine, a component of atherogenic lipoproteins, induces mononuclear leukocyte adhesion molecules in cultured human and rabbit arterial endothelial cells. J Clin Invest 1992;90:1138-44.
22. Gebuhrer V, Murphy JF, Bordet JC, Reck MP, McGregor JL. Oxidized low-density lipoprotein induces the expression of P-selectin (GMP 140/PADGEM/CD62) on human endothelial cells. Biochem J 1995;306:293-8.
23. Khan BV, Parthasarathy SS, Alexander RW, Medford RM. Modified low density lipoprotein and its constituents augment cytokine-activated vascular cell adhesion molecule-1 gene expression in human vascular endothelial cells. J Clin Invest 1995;95:1262-70.
24. Cockerill GW, Rye KA. Gamble JR, Vadas MA, Barter PJ. High-density lipoproteins inhibit cytokine-induced expression of endothelial cell adhesion molecules. Arterioscler Thromb Vasc Biol 1995;15:1987-94.
25. Navab M, Berliner JA, Watson AD et al. The Yin and Yang of oxidation in the development of the fatty streak: a review based on the 1994 George Lyman Duff Memorial Lecture. Arterioscler Thromb Vasc Biol 1996;16:831-42.
26. Khoo JC, Miller E, McLoughlin P, Steinberg D. Enhanced macrophage uptake of low density lipoprotein after self-aggregation. Atherosclerosis 1988;8:348-58.
27. Griendling KK, Alexander RW. Oxidative stress and cardiovascular disease. Circulation 1997;96:3264-5.
28. Yla-Herttuala S, Palinski W, Rosenfeld ME et al. Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions rabbit and man. J Clin Invest 1989;84:1086-95.
29. Libby P, Aikawa M, Kinlay S, Selwyn A, Ganz P. Lipid lowering improves endothelial functions. Int J Cardiol 2000;74:S3-S10.
30. Diaz MN, Frei B, Vita JA, Keaney JF Jr. Antioxidants and atherosclerotic heart disease. N Engl J Med 1997;337:408-16.
31. Davies MJ, Gordon JL, Gearing AJ et al. The expression of the adhesion molecules ICAM-1, VCAM-1, PECAM, and E-selectin in human atherosclerosis. J Pathol 1993;171:223-9.
32. Richardson M, Hadcock SJ. DeReske M, Cybulsky MI. Increased expression in vivo of VCAM-1 and E-selectin by the aortic endothelium of normolipemic and hyperlipemic diabetic rabbits. Arterioscler Thromb 1994;14:760-9.
33. Johnson-Tidey RR,. McGregor JL, Taylor PR, Poston RN. Increase in the adhesion molecule P-selectin in endothelium overlying atherosclerotic plaques: coexpression with intercellular adhesion molecule-1. Am J Pathol 1994:144:952-61.
34. Johnson RC, Chapman SM, Dong ZM et al. Absence of P-selectin delays fatty streak formation in mice. J Clin Invest 1997;99:1037-43.
35. Ramos CL, Huo Y, Jung U et al. Direct demonstration of P-selectin and VCAM-1 dependent mononuclear cell rolling in early atherosclerotic lesions of apolipoprotein E-deficient mice. Circ Res 1999;84:1237-44.
36. Pigott R, Dillon LP, Hemingway IH, Gearing AJ. Soluble forms of E-selectin, ICAM-1 and VCAM-1 are present in the supernatants of cytokine activated cultured endothelial cell. Biochem Biophys Res Commun 1992;187:584-9.
37. Sampietro T, Tuoni M, Ferdeghini M et al. Plasma cholesterol regulates soluble cell adhesion molecule expression in familial hypercholesterolemia. Circulation 1997;96:1381-5.
38. Blann AD, Goode GK, Miller JP, McCollum CN. Soluble P-selectin in hyperlipidaemia with and without symptomatic vascular disease, relationship with von Willebrand factor. Blood Coagul Fibrinolysis 1997;8:200-4.
39. Niwa S, Totsuka T, Hayashi S. Inhibitory effect of Fluvastatin, an HMG-CoA reductase inhibitor, on the expression of adhesion molecules on human monocyte cell line. Int J Immunopharmacol 1996;18:669-75.
40. Rauch U, Osende JI, Chesebro JH et al. Statins and cardiovascular disease: the multiple effects of lipid-lowering therapy by statins. Atherosclerosis 2000;153:181-9.
41. Yamane S, Matsugane T, Motohashi K et al. Double filtration plasmapheresis maintains normal adhesion molecule levels. Ther Apher 1998;2:224-7.
42. Richter V, Rassoul F, Reuter W et al. Effect of extracorporeal low-density lipoprotein elimination on circulating cell adhesion molecules in patients with hypercholesterolemia. Am J Cardiol 2001;87:1111-3,A9.
43. Empen K, Otto C, Brodl UC, Parhofer KG. The effects of three different LDL apheresis methods on the plasma concentrations of E-selectin,VCAM-1, and ICAM-1. J Clin Apheresis 2002;17:38-43.
44. Bambauer R, Olbricht CJ, Schoeppe E. Low-density lipoprotein apheresis for prevention and regression of atherosclerosis: Clinical results. Ther Apher 1997;1:242-8.
45. Cattin L, Petrucco A, Cazzolato G et al. Low density lipoprotein-apheresis decreases oxidized low density lipoproteins and monocyte adhesion to endothelial cells. ASAIO J 1997;43:209-13.
46. Mocco J, Choudhri TF, Mack WJ et al. Elevation of soluble intercellular adhesion molecule-1 levels in symptomatic and asymptomatic carotid atherosclerosis. Neurosurgery 2001;48:718-21.
47. John S, Jacobi J, Delles C, Schlaich MP, Alter O, Schmieder RE. Plasma soluble adhesion molecules and endothelium-dependent vasodilation in early human atherosclerosis. Clin Sci (Lond) 2000;98:521-9.
48. Paiker JE, Raal FJ, Veller M, von Arb M, Chetty N, Naran NH. Cell adhesion molecules-can they be used to predict coronary artery disease in patients with familial hypercholesterolaemia? Clin Chim Acta 2000;293:105-13.